The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.

Standard

The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. / Cavanna, A E; Schrag, A; Morley, D; Orth, Michael; Robertson, M M; Joyce, E; Critchley, H D; Selai, C.

In: NEUROLOGY, Vol. 71, No. 18, 18, 2008, p. 1410-1416.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Cavanna, AE, Schrag, A, Morley, D, Orth, M, Robertson, MM, Joyce, E, Critchley, HD & Selai, C 2008, 'The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.', NEUROLOGY, vol. 71, no. 18, 18, pp. 1410-1416. <http://www.ncbi.nlm.nih.gov/pubmed/18955683?dopt=Citation>

APA

Cavanna, A. E., Schrag, A., Morley, D., Orth, M., Robertson, M. M., Joyce, E., Critchley, H. D., & Selai, C. (2008). The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. NEUROLOGY, 71(18), 1410-1416. [18]. http://www.ncbi.nlm.nih.gov/pubmed/18955683?dopt=Citation

Vancouver

Cavanna AE, Schrag A, Morley D, Orth M, Robertson MM, Joyce E et al. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. NEUROLOGY. 2008;71(18):1410-1416. 18.

Bibtex

@article{204ae44da206444cb4d521ac5dbf8e1c,
title = "The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.",
abstract = "BACKGROUND: Gilles de la Tourette syndrome (GTS) is a chronic neuropsychiatric disorder which has a significant detrimental impact on the health-related quality of life (HR-QOL) of patients. However, no patient-reported HR-QOL measures have been developed for this population. OBJECTIVE: The development and validation of a new scale for the quantitative assessment of HR-QOL in patients with GTS. METHODS: In stage 1 (item generation), a pool of 40 potential scale items was generated based on interviews with 133 GTS outpatients, literature review, and consultation with experts. In stage 2 (scale development), these items were administered to a sample of 192 GTS outpatients. Standard statistical methods were used to develop a rating scale satisfying criteria for acceptability, reliability, and validity. In stage 3 (scale evaluation), the psychometric properties of the resulting scale were tested in a second sample of 136 subjects recruited through the UK-Tourette Syndrome Association. RESULTS: Response data analysis and item reduction methods led to a final 27-item GTS-specific HR-QOL scale (GTS-QOL) with four subscales (psychological, physical, obsessional, and cognitive). The GTS-QOL demonstrated satisfactory scaling assumptions and acceptability; both internal consistency reliability and test-retest reliability were high (Cronbach alpha > or =0.8 and intraclass correlation coefficient > or =0.8); validity was supported by interscale correlations (range 0.5-0.7), confirmatory factor analysis, and correlation patterns with other rating scales and clinical variables. CONCLUSIONS: The Gilles de la Tourette syndrome (GTS)-specific health-related quality of life (HR-QOL) scale (GTS-QOL) is proposed as a new disease-specific patient-reported scale for the measurement of HR-QOL in patients with GTS, taking into account the complexity of the clinical picture of GTS.",
author = "Cavanna, {A E} and A Schrag and D Morley and Michael Orth and Robertson, {M M} and E Joyce and Critchley, {H D} and C Selai",
year = "2008",
language = "Deutsch",
volume = "71",
pages = "1410--1416",
journal = "NEUROLOGY",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "18",

}

RIS

TY - JOUR

T1 - The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.

AU - Cavanna, A E

AU - Schrag, A

AU - Morley, D

AU - Orth, Michael

AU - Robertson, M M

AU - Joyce, E

AU - Critchley, H D

AU - Selai, C

PY - 2008

Y1 - 2008

N2 - BACKGROUND: Gilles de la Tourette syndrome (GTS) is a chronic neuropsychiatric disorder which has a significant detrimental impact on the health-related quality of life (HR-QOL) of patients. However, no patient-reported HR-QOL measures have been developed for this population. OBJECTIVE: The development and validation of a new scale for the quantitative assessment of HR-QOL in patients with GTS. METHODS: In stage 1 (item generation), a pool of 40 potential scale items was generated based on interviews with 133 GTS outpatients, literature review, and consultation with experts. In stage 2 (scale development), these items were administered to a sample of 192 GTS outpatients. Standard statistical methods were used to develop a rating scale satisfying criteria for acceptability, reliability, and validity. In stage 3 (scale evaluation), the psychometric properties of the resulting scale were tested in a second sample of 136 subjects recruited through the UK-Tourette Syndrome Association. RESULTS: Response data analysis and item reduction methods led to a final 27-item GTS-specific HR-QOL scale (GTS-QOL) with four subscales (psychological, physical, obsessional, and cognitive). The GTS-QOL demonstrated satisfactory scaling assumptions and acceptability; both internal consistency reliability and test-retest reliability were high (Cronbach alpha > or =0.8 and intraclass correlation coefficient > or =0.8); validity was supported by interscale correlations (range 0.5-0.7), confirmatory factor analysis, and correlation patterns with other rating scales and clinical variables. CONCLUSIONS: The Gilles de la Tourette syndrome (GTS)-specific health-related quality of life (HR-QOL) scale (GTS-QOL) is proposed as a new disease-specific patient-reported scale for the measurement of HR-QOL in patients with GTS, taking into account the complexity of the clinical picture of GTS.

AB - BACKGROUND: Gilles de la Tourette syndrome (GTS) is a chronic neuropsychiatric disorder which has a significant detrimental impact on the health-related quality of life (HR-QOL) of patients. However, no patient-reported HR-QOL measures have been developed for this population. OBJECTIVE: The development and validation of a new scale for the quantitative assessment of HR-QOL in patients with GTS. METHODS: In stage 1 (item generation), a pool of 40 potential scale items was generated based on interviews with 133 GTS outpatients, literature review, and consultation with experts. In stage 2 (scale development), these items were administered to a sample of 192 GTS outpatients. Standard statistical methods were used to develop a rating scale satisfying criteria for acceptability, reliability, and validity. In stage 3 (scale evaluation), the psychometric properties of the resulting scale were tested in a second sample of 136 subjects recruited through the UK-Tourette Syndrome Association. RESULTS: Response data analysis and item reduction methods led to a final 27-item GTS-specific HR-QOL scale (GTS-QOL) with four subscales (psychological, physical, obsessional, and cognitive). The GTS-QOL demonstrated satisfactory scaling assumptions and acceptability; both internal consistency reliability and test-retest reliability were high (Cronbach alpha > or =0.8 and intraclass correlation coefficient > or =0.8); validity was supported by interscale correlations (range 0.5-0.7), confirmatory factor analysis, and correlation patterns with other rating scales and clinical variables. CONCLUSIONS: The Gilles de la Tourette syndrome (GTS)-specific health-related quality of life (HR-QOL) scale (GTS-QOL) is proposed as a new disease-specific patient-reported scale for the measurement of HR-QOL in patients with GTS, taking into account the complexity of the clinical picture of GTS.

M3 - SCORING: Zeitschriftenaufsatz

VL - 71

SP - 1410

EP - 1416

JO - NEUROLOGY

JF - NEUROLOGY

SN - 0028-3878

IS - 18

M1 - 18

ER -